In vivo inhibition of Novikoff cytoplasmic messenger RNA methylation by S-tubercidinylhomocysteine.
The analogue S-tubercidinylhomocysteine (STH) has been used to study the methylation of mRNA in vivo. Partial inhibition of cytoplasmic poly(A)-RNA methylation was observed using a level of inhibitor which still permitted cell growth. Characterization of the partially methylated mRNA indicated the presence of cap structures lacking 2'-O-methylnucleosides, m7GpppN', which are normally not found in mammalian mRNA. Inhibition of additional methylated sites in mRNA at the second 2'-O-methynucleoside, and at internal N6-methyladenosine was also observed Methylation of 7-methylguanosine was not affected under the conditions used in these experiments. The methylnucleoside composition of cap structures differed in STH-inhibited and uninhibited cells. These results indicate that a completely methylated cap is not required for transport of mRNA into the cytoplasm. Furthermore, it may now be possible to assess in vivo the sequential nature of mRNA methylation and its potential role in mRNA processing.
D006528:Carcinoma, Hepatocellular / Q000378:metabolism; D002460:Cell Line; D006710:Homocysteine / Q000031:analogs & derivatives*; D008113:Liver Neoplasms / Q000378:metabolism; D009374:Neoplasms, Experimental / Q000378:metabolism; D009843:Oligoribonucleotides / Q000032:analysis; D011061:Poly A / Q000096:biosynthesis; D012333:RNA, Messenger / Q000096:biosynthesis*; D012435:S-Adenosylhomocysteine / Q000031:analogs & derivatives* / Q000494:pharmacology
D009843:Oligoribonucleotides; D012333:RNA, Messenger; D006710:Homocysteine; D011061:Poly A; C012086:S-tubercidinylhomocysteine; D012435:S-Adenosylhomocysteine